Breaking News Instant updates and real-time market news.

EOLS

Evolus

$20.23

0.22 (1.10%)

08:18
08/29/18
08/29
08:18
08/29/18
08:18

Evolus announces acceptance of FDA BLA resubmission for prabotulinumtoxinA

Evolus announced the acceptance of its resubmission of its biologics license application, or BLA, for its lead product candidate, prabotulinumtoxinA, by the FDA. The FDA considered the resubmission a Class 2 response and has assigned a February 2, 2019 action date per the Prescription Drug User Fee Act.

EOLS Evolus
$20.23

0.22 (1.10%)

05/29/18
JMPS
05/29/18
NO CHANGE
Target $30
JMPS
Outperform
Evolus price target raised to $30 after executive hirings at JMP Securities
After Evolus (EOLS) announced that it hired Lauren Silvernail, formerly the CFO at Revance Therapeutics (RVNC), to be its own CFO, JMP Securities analyst Donald Ellis noted this was the second hiring by the company of a C-suite executive from a major competitor after the company had previously hired CEO David Moatazedi from Allergan (AGN). The analyst, who contends that both Moatazedi and Silvernail "have voted with their feet for the winner in the aesthetic toxin market," increased his view of the probability of approval for DWP-450 to 100% from 80%, which drove up his price target on Evolus shares to $30 from $22. Ellis maintains his Outperform rating on Evolus.
06/11/18
MZHO
06/11/18
NO CHANGE
Target $33
MZHO
Buy
Evolus price target raised to $33 from $16 at Mizuho
Mizuho analyst Irina Koffler raised her price target for Evolus to $33 citing lower risk and higher market growth expectations. The analyst reiterates a Buy rating on the shares.
06/13/18
CANT
06/13/18
NO CHANGE
Target $35
CANT
Overweight
Evolus price target raised to $35 from $25 at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen raised her price target for Evolus to $35 citing improved visibility for the peak sales potential of DWP-450. Although Evolus is not providing the details of its Complete Response Letter, the company said that over half of the questions listed in the CRL have been resolved, Chen tells investors in a research note. The analyst continues to see a "smooth" path to approval and keeps an Overweight rating on Evolus shares.
08/02/18
JMPS
08/02/18
NO CHANGE
Target $35
JMPS
Outperform
Evolus price target raised to $35 from $30 at JMP Securities
JMP Securities analyst Donald Ellis raised his price target for Evolus (EOLS) to $35 and reiterates an Outperform rating on the shares following the company's Q2 results. The analyst now assumes that DWP-450 will price at a 10% price discount relative to Allergan's (AGN) Botox versus 20% previously. He notes that DWP-450 will not go to market as simply a "generic" Botox, but rather a branded player with a "with a smart go-to-market strategy." The Evolus management team is "carefully and thoughtfully building an aesthetic only major player in the U.S. cosmetic market," Ellis tells investors in a research note.

TODAY'S FREE FLY STORIES

BBT

BB&T

$51.56

0.59 (1.16%)

12:10
09/20/18
09/20
12:10
09/20/18
12:10
Conference/Events
BB&T management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 18

    Oct

GE

General Electric

$12.45

-0.415 (-3.23%)

, UAA

Under Armour

$19.93

1.175 (6.27%)

12:09
09/20/18
09/20
12:09
09/20/18
12:09
General news
Fly Intel: Wall Street's top stories at midday »

Stocks opened in positive…

GE

General Electric

$12.45

-0.415 (-3.23%)

UAA

Under Armour

$19.93

1.175 (6.27%)

DIS

Disney

$111.69

1.81 (1.65%)

FOXA

21st Century Fox

$44.71

0.11 (0.25%)

CMCSA

Comcast

$37.54

0.22 (0.59%)

CRBP

Corbus Pharmaceuticals

$6.90

1.75 (33.98%)

FOLD

Amicus

$12.72

0.92 (7.80%)

SFIX

Stitch Fix

$41.40

-5.81 (-12.31%)

THO

Thor Industries

$92.25

-13.47 (-12.74%)

RHT

Red Hat

$134.22

-9.16 (-6.39%)

FOX

21st Century Fox

$44.34

0.09 (0.20%)

CMCSK

Comcast

$0.00

(0.00%)

UA

Under Armour

$18.29

1.01 (5.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 01

    Oct

  • 27

    Nov

NSANY

Nissan

$0.00

(0.00%)

12:07
09/20/18
09/20
12:07
09/20/18
12:07
Hot Stocks
Nissan recalls over 215,000 vehicles in U.S. for antilock brake pump defect »

Nissan North America is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:05
09/20/18
09/20
12:05
09/20/18
12:05
General news
Libor has been moving higher »

Libor has been moving…

SKY

Skyline

$28.20

-2.405 (-7.86%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Skyline falls -7.9% »

Skyline is down -7.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

SSW

Seaspan

$8.05

-1.105 (-12.08%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Seaspan falls -12.2% »

Seaspan is down -12.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THO

Thor Industries

$92.17

-13.55 (-12.82%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Thor Industries falls -12.8% »

Thor Industries is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTL

Mechel

$3.29

0.335 (11.34%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Mechel rises 12.8% »

Mechel is up 12.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEW

Puxin Limited

$8.51

0.94 (12.42%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
Puxin Limited rises 13.2% »

Puxin Limited is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$60.26

0.95 (1.60%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Options
Monster Beverage option volume is 3X daily average and calls lead puts 10:1 »

Monster Beverage option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COE

China Online Education

$7.00

(0.00%)

12:00
09/20/18
09/20
12:00
09/20/18
12:00
Hot Stocks
China Online Education rises 15.9% »

China Online Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPOA

Social Capital

$9.88

-0.05 (-0.50%)

11:55
09/20/18
09/20
11:55
09/20/18
11:55
Hot Stocks
Social Capital's Palihapitiya says no longer accepting new outside capital »

In a Medium post entitled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
09/20/18
09/20
11:55
09/20/18
11:55
Conference/Events
William Blair business services analyst holds group luncheon »

Business Services Analyst…

11:55
09/20/18
09/20
11:55
09/20/18
11:55
Conference/Events
Stephens specialty finance analyst to hold a group luncheon »

Specialty Finance Analyst…

MGTI

MGT Capital Investments

$0.00

(0.00%)

11:52
09/20/18
09/20
11:52
09/20/18
11:52
Hot Stocks
MGT Capital Investments announces partnership with MMH Blockchain »

MGT Capital Investments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXTA

Axalta Coating

$30.16

0.23 (0.77%)

11:50
09/20/18
09/20
11:50
09/20/18
11:50
Options
Axalta Coating Systems attracts bullish option spreads »

Axalta Coating Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAF

GrafTech

$20.10

1.015 (5.32%)

11:49
09/20/18
09/20
11:49
09/20/18
11:49
Recommendations
GrafTech analyst commentary  »

GrafTech selloff brings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

11:45
09/20/18
09/20
11:45
09/20/18
11:45
Options
Tandem Diabetes call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Nov

BYSI

BeyondSpring

$25.55

(0.00%)

11:44
09/20/18
09/20
11:44
09/20/18
11:44
Conference/Events
BeyondSpring management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

11:43
09/20/18
09/20
11:43
09/20/18
11:43
Conference/Events
RBC Capital healthcare tech analyst to hold analyst/industry conference call »

Healthcare Technology…

EB

Eventbrite

$0.00

(0.00%)

11:36
09/20/18
09/20
11:36
09/20/18
11:36
Syndicate
Breaking Syndicate news story on Eventbrite »

Eventbrite opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

DNR

Denbury Resources

$5.49

-0.095 (-1.70%)

11:35
09/20/18
09/20
11:35
09/20/18
11:35
Options
Denbury Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.79

0.03 (0.03%)

11:28
09/20/18
09/20
11:28
09/20/18
11:28
Syndicate
Elanco opens at $32.25, IPO priced at $24.00 per share »

Elanco Animal Health…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.79

0.03 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

ELAN

Elanco

$0.00

(0.00%)

, LLY

Eli Lilly

$105.64

-0.12 (-0.11%)

11:25
09/20/18
09/20
11:25
09/20/18
11:25
Syndicate
Breaking Syndicate news story on Elanco, Eli Lilly »

Elanco indicated to open…

ELAN

Elanco

$0.00

(0.00%)

LLY

Eli Lilly

$105.64

-0.12 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 01

    Oct

  • 01

    Oct

  • 04

    Oct

  • 20

    Sep

RF

Regions Financial

$19.41

0.25 (1.30%)

11:25
09/20/18
09/20
11:25
09/20/18
11:25
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.